Fortress Biotech
FBIO
57 hedge funds and large institutions have $22.3M invested in Fortress Biotech in 2014 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 23 increasing their positions, 10 reducing their positions, and 13 closing their positions.
495% more call options, than puts
Call options by funds: $1.45M | Put options by funds: $243K
130% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 10
5% less funds holding
Funds holding: 60 → 57 (-3)
15% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 13
27% less capital invested
Capital invested by funds: $30.6M → $22.3M (-$8.27M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$929K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$796K |
| 3 |
ACM
Advent Capital Management
New York
|
+$627K |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$371K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$270K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$893K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$874K |
| 3 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$830K |
| 4 |
JG
Jefferies Group
New York
|
-$681K |
| 5 |
MOACM
Mutual of America Capital Management
New York
|
-$604K |
FBIO Hedge Fund Activity: Q1 2014 in Review
57 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in Fortress Biotech (FBIO) for Q1 2014, worth a combined $22.3M — down 27% from $30.6M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of FBIO and 11 opened new positions — a net loss of 2 holders — while 10 trimmed existing stakes and 23 added.
The largest buyer was Renaissance Technologies, adding an estimated $929K. The largest seller was Oxford Asset Management, exiting entirely with an estimated $893K sold.
- 57 institutional investors held Fortress Biotech (FBIO) as of Q1 2014, down from 60 in Q4 2013.
- Funds reported $22.3M of Fortress Biotech stock for Q1 2014, down 27% quarter-over-quarter.
- 11 funds opened new Fortress Biotech positions in Q1 2014 and 13 closed out, a net change of -2 holders.
- The largest Fortress Biotech buyer in Q1 2014 was Renaissance Technologies, an estimated $929K added.
- The largest Fortress Biotech seller in Q1 2014 was Oxford Asset Management, an estimated $893K sold.
Based on aggregated 13F filings for Q1 2014.